Efficacy and Safety of Colistin versus Tigecycline for Multi-Drug-Resistant and Extensively Drug-Resistant Gram-Negative Pathogens—A Meta-Analysis

Background: We intended to compare the efficacy and safety outcomes of colistin versus tigecycline as monotherapy or combination therapy against multi-drug resistant (MDR) and extensively drug-resistant (XDR) pathogens. Methods: A search was conducted in PubMed, Cochrane CENTRAL, EMBASE, and in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Abushanab, Dina, Nasr, Ziad G., Al-Badriyeh, Daoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686723/
https://www.ncbi.nlm.nih.gov/pubmed/36421274
http://dx.doi.org/10.3390/antibiotics11111630

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686723/
https://www.ncbi.nlm.nih.gov/pubmed/36421274
http://dx.doi.org/10.3390/antibiotics11111630

Ejemplares similares